Andra Bălănescu

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update

Laure Gossec, Xenofon Baraliakos, Andreas Kerschbaumer et al. · Annals of the Rheumatic Diseases · 2020 · 948 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative

Laure Gossec, Maarten de Wit, Uta Kiltz et al. · Annals of the Rheumatic Diseases · 2014 · 421 citations · Full text

Medicine, Clinical Sciences, Health Assessment +16

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative

Laure Gossec, S. Paternotte, G. J. Aanerud et al. · Annals of the Rheumatic Diseases · 2011 · 294 citations · Full text

Pharmacy, Internal Medicine, Functional Assessment +16

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative

Laure Gossec, Maxime Dougados, Nathalie Rincheval et al. · Annals of the Rheumatic Diseases · 2008 · 245 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12